Intuitive Surgical, Inc.

Valuation Analysis

About the Company

Intuitive Surgical, Inc. en bref

Intuitive Surgical, Inc. (ISRG) is currently trading at 354,62 € with a market capitalization of 125,6 Md €. The trailing P/E ratio stands at 49.49x, with a forward P/E of 34.51x. The 52-week range spans from 345,81 € to 526,44 €; the current price is 32.6% below the yearly high. Year-over-year revenue growth stands at +23.0%. The net profit margin stands at 28.15%.

💰 Dividende

Intuitive Surgical, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

29 analystes évaluent Intuitive Surgical, Inc. (ISRG) au consensus : Acheter. L'objectif de cours moyen est de 492,62 €, soit un potentiel de +38.92% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 319,07 € à 653,82 €.

Intuitive Surgical, Inc. : la thèse d'investissement en détail

Intuitive Surgical, Inc. (ISRG) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 23% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 66.29%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Free cash flow is positive and net margins stand at 28.15%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

Le scénario baissier

Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

The EV/EBITDA multiple of 36.88x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

À surveiller

• The forward P/E of 34.51x is meaningfully below the trailing 49.49x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 38.92% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to market-like volatility.

Trading Data

Related Stocks in the Same Sector

Where can I buy Intuitive Surgical, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.